Skip to main content
Premium Trial:

Request an Annual Quote

ChromaCode Receives FDA Emergency Use Authorization for SARS-CoV-2 PCR Test

NEW YORK – Software and reagent technology firm ChromaCode announced Wednesday its HDPCR SARS-CoV-2 Real-Time PCR assay received Emergency Use Authorization from the US Food and Drug Administration.

The test detects the virus from nasopharyngeal swab specimens and runs on standard qPCR instruments, including Thermo Fisher Scientific's Applied Biosystems 7500 Fast machine. Labs can run more than 1,000 samples per qPCR instrument in 24 hours, the firm said.

ChromaCode Co-founder, President, and CEO Greg Gosch added in a statement that the firm "guarantees ongoing supply for customers who sign an agreement" with it. Later this year, the firm said it will launch a SARS-CoV-2 test combining multiple respiratory viruses into a single test in preparation for the upcoming flu season. 

According to the Carlsbad, California-based company, it uses data science technology and cloud-computing algorithms to boost performance of common molecular diagnostic instruments and reagents, and its high-definition PCR technology expands the number of detectable disease targets in a single reaction.

Last month, the firm announced it had raised a total of $38 million in a Series C financing round, which it will use to continue developing the HDPCR platform and further its global expansion in resource-limited communities.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.